Latest Dual Listing News

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

Benz Mining Corp. has raised A$75 million through a bought deal placement, significantly strengthening its cash reserves to nearly A$94 million. This capital injection will accelerate exploration and resource development at its Glenburgh and Mt Egerton Gold Projects in Western Australia.

Minerals Exploration Limited has kicked off a maiden 3,000m diamond drilling campaign at its flagship Waitekauri Gold Project in New Zealand, targeting historically rich high-grade gold zones. Early rock chip assays and historic data suggest promising potential for a multi-million-ounce resource.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Bioxyne Limited has posted a record $17.2 million in quarterly revenue for Q2 FY26, driven by strong growth in its cannabis and psychedelics segments alongside strategic international expansions.

Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.

American Tungsten & Antimony Ltd is progressing its Nasdaq listing plans with a confidential SEC filing expected in March 2026 and has appointed Deutsche Bank as ADR depositary alongside a new CFO to support growth.

Chilwa Minerals has finalised the last tranche of its $8 million private placement, bolstered by insider participation, and is advancing plans for a Nasdaq dual listing in the first half of 2026.

Argent BioPharma has signed a binding agreement to acquire AusCann’s 48% stake in CannPal, enhancing its clinical and intellectual property assets for CannEpil®. The deal includes an option for the Neuvis® drug-delivery platform and aligns with Argent’s U.S. dual-listing ambitions.

Rio Tinto and Glencore have entered preliminary talks about a possible all-share merger via a Court-sanctioned scheme of arrangement, though no firm offer has been made. The mining giants have until early February to decide on progressing the deal.

Nova Minerals’ 2025 drilling at the RPM North deposit in Alaska confirms significant eastern extensions and broad near-surface gold zones, underpinning potential resource upgrades ahead of a key Pre-Feasibility Study.

Robex Resources shareholders have overwhelmingly approved a merger with Predictive Discovery, setting the stage for a leading gold producer in West Africa with combined annual output projected to exceed 400,000 ounces by 2029.